We are live on ! Find out more
AA

AQR Arbitrage Portfolio holdings

AUM $6.09B
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
+3.38%
1 Year Est. Return
+27.01%
3 Year Est. Return
+77.25%
5 Year Est. Return
+160.09%
10 Year Est. Return
+1,244.43%
AUM
$4.36B
AUM Growth
+$127M
Cap. Flow
-$883M
Cap. Flow %
-20.26%
Top 10 Hldgs %
23.47%
Holding
494
New
108
Increased
21
Reduced
89
Closed
104

Sector Composition

Rank Sector Weight
1 Financials 22.27%
2 Energy 6.34%
3 Technology 4.75%
4 Healthcare 4.23%
5 Utilities 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCIXW
301
Churchill Capital Corp IX Warrant
CCIXW
$71.9K
$49.4K ﹤0.01%
49,400
ASPCR
302
A SPAC III Acquisition Corp Right
ASPCR
$44.9K ﹤0.01%
249,459
ESHAR
303
DELISTED
ESH Acquisition Corp Right
ESHAR
$44.5K ﹤0.01%
523,991
HSPOR
304
DELISTED
Horizon Space Acquisition I Corp Right
HSPOR
$44.3K ﹤0.01%
246,133
DMYY.WS
305
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
$43.5K ﹤0.01%
22,759
DISTR
306
DELISTED
Distoken Acquisition Corporation Right
DISTR
$35.1K ﹤0.01%
125,000
UYSCR
307
UY Scuti Acquisition Corp Rights
UYSCR
$35K ﹤0.01%
+175,000
New +$35.4K
SVIIW
308
DELISTED
Spring Valley Acquisition Corp II Warrant
SVIIW
$32.1K ﹤0.01%
229,541
BOWNR
309
DELISTED
Bowen Acquisition Corp Rights
BOWNR
$31.2K ﹤0.01%
148,626
IBACR
310
IB Acquisition Corp Right
IBACR
$30.5K ﹤0.01%
741,594
UCFIW
311
CN Healthy Food Tech Group Warrant
UCFIW
$27K ﹤0.01%
449,726
-5,531
-1% -$232
CHEB.WS
312
DELISTED
Chenghe Acquisition II Co. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CHEB.WS
$24.4K ﹤0.01%
406,650
-10,325
-2% -$801
BGLWW
313
Blue Gold Ltd Warrant
BGLWW
$914K
$22.5K ﹤0.01%
+118,227
New +$22.9K
EMCGR
314
DELISTED
Embrace Change Acquisition Corp Rights
EMCGR
$22.1K ﹤0.01%
193,214
EURKR
315
Eureka Acquisition Corp Right
EURKR
$21.8K ﹤0.01%
99,076
ALCYW
316
DELISTED
Alchemy Investments Acquisition Corp 1 Warrants
ALCYW
$21.4K ﹤0.01%
201,748
OAKUR
317
DELISTED
Oak Woods Acquisition Corp Right
OAKUR
$19K ﹤0.01%
95,000
CYCUW
318
Cycurion Inc Warrant
CYCUW
$198K
$18.9K ﹤0.01%
314,189
-20,185
-6% -$1.05K
ABP
319
DELISTED
Abpro Holdings
ABP
$18.6K ﹤0.01%
2,917
EUDAW icon
320
EUDA Health Holdings Warrant
EUDAW
$219K
$14.2K ﹤0.01%
108,967
-479
-0.4% -$61
FORLW
321
DELISTED
Four Leaf Acquisition Corp Warrants
FORLW
$13.1K ﹤0.01%
437,027
DISTW
322
DELISTED
Distoken Acquisition Corporation Warrant
DISTW
$13.1K ﹤0.01%
117,869
-7,131
-6% -$526
ABPWW
323
DELISTED
Abpro Holdings Warrant
ABPWW
$12K ﹤0.01%
579,134
-52,591
-8% -$1.19K
HSPOW
324
DELISTED
Horizon Space Acquisition I Corp Warrant
HSPOW
$9.85K ﹤0.01%
246,133
FOXXW
325
Foxx Development Holdings Warrant
FOXXW
$9.25K ﹤0.01%
77,053
-469
-0.6% -$67

Similar funds

AQR Arbitrage's Q2 2025 Portfolio in Review

As of Q2 2025, AQR Arbitrage held 494 positions worth $4.36B, up 3% from $4.23B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

AQR Arbitrage withdrew a net $883M in Q2 2025, closing 104 positions and reducing 89 holdings. Its most notable exit was Discover Financial Services, an estimated $78M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 20% a quarter earlier, followed by Energy and Technology.

Against the trend, AQR Arbitrage opened a new position in SpringWorks Therapeutics worth $62M.

  • AQR Arbitrage's largest Q2 2025 buy was SpringWorks Therapeutics: 1,319,782 shares worth $62M.
  • AQR Arbitrage added most to Hess in Q2 2025, an estimated $63M increase.
  • AQR Arbitrage's biggest Q2 2025 reduction was GSR III Acquisition Corp, cutting an estimated $12.6M.
  • AQR Arbitrage fully exited Discover Financial Services in Q2 2025, selling an estimated $78M.
  • AQR Arbitrage's ten largest holdings make up 23% of its $4.36B portfolio in Q2 2025.
  • AQR Arbitrage opened 108 new positions and closed 104 in Q2 2025.
  • AQR Arbitrage's portfolio value rose 3% quarter-over-quarter to $4.36B.

Based on AQR Arbitrage's 13F filing for Q2 2025, filed 14 Aug 2025.